The Microarray-Bioinformatics Core in Pulmonary Biology is a new core that is dedicated to assist PPG investigators in design and analysis of comprehensive microarray experiments to achieve high quality, statistically solid and biologically relevent results. We will provide direct analytic support and training in the following areas: (1) Experimental design (2) Microarray data mining (3) Promoter analysis (4) Literature mining and pathway mapping (5) Gene expression data management and database application The Core will be directed by Dr. Yan Xu, an experienced Genomics/Bioinformatics specialist, who will provide scientific expertise and working closely with PPG investigators in Cincinnati Children's Hospital, Pediatric Informatics group (lead by Dr. John Pestian and Dr. Bruce Aronow) and Children's Hospital Affymetrix Core (lead by Dr. Steven Potter). The Core will provide bioinformatics support and training on all aspects ofmicroarray experiment design, data accessing and processing for all PPG projects, construct and update gene expression databases for microarray data storage and organize and publish final results in a web server so all PPG investigators can review their data at any time. The Pediatric Informatics at CCHMC is a new established division with team of experts in the fields ofbioinformatics, computational biology, computer science, developmental biology, health services research, mathematics and medicine. Our Informatics core support includes an exceptional collection of high performance computing systems and bioinformatics software, which together form the nation's f'trst su_percomputing facility for pediatric clinical and genomics research. These resources will be available to PPG participants. In addition, the Pediatric Informatics group specializes in developing custom software applications and provide training, both in small classroom sessions and online, to all CCHMC users.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL061646-10
Application #
7637817
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
10
Fiscal Year
2008
Total Cost
$218,249
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Whitsett, Jeffrey A; Weaver, Timothy E (2015) Alveolar development and disease. Am J Respir Cell Mol Biol 53:1-7
Conkright, Juliana J; Apsley, Karen S; Martin, Emily P et al. (2010) Nedd4-2-mediated ubiquitination facilitates processing of surfactant protein-C. Am J Respir Cell Mol Biol 42:181-9
Xu, Yan; Zhang, Minlu; Wang, Yanhua et al. (2010) A systems approach to mapping transcriptional networks controlling surfactant homeostasis. BMC Genomics 11:451
Suzuki, Takuji; Sakagami, Takuro; Young, Lisa R et al. (2010) Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy. Am J Respir Crit Care Med 182:1292-304
Hardie, William D; Hagood, James S; Dave, Vrushank et al. (2010) Signaling pathways in the epithelial origins of pulmonary fibrosis. Cell Cycle 9:2769-76
Whitsett, Jeffrey A; Wert, Susan E; Weaver, Timothy E (2010) Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med 61:105-19
Kramer, Elizabeth L; Mushaben, Elizabeth M; Pastura, Patricia A et al. (2009) Early growth response-1 suppresses epidermal growth factor receptor-mediated airway hyperresponsiveness and lung remodeling in mice. Am J Respir Cell Mol Biol 41:415-25
Wang, Mei; Bridges, James P; Na, Cheng-Lun et al. (2009) Meckel-Gruber syndrome protein MKS3 is required for endoplasmic reticulum-associated degradation of surfactant protein C. J Biol Chem 284:33377-83
Hardie, William D; Glasser, Stephan W; Hagood, James S (2009) Emerging concepts in the pathogenesis of lung fibrosis. Am J Pathol 175:3-16
Korfhagen, Thomas R; Le Cras, Timothy D; Davidson, Cynthia R et al. (2009) Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 41:562-72

Showing the most recent 10 out of 91 publications